ABCB7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.006400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.418000E-02
Normal-vs-Stage2
8.308100E-02
Normal-vs-Stage3
8.821800E-02
Normal-vs-Stage4
8.767000E-01
Stage1-vs-Stage2
7.534600E-01
Stage1-vs-Stage3
2.228200E-01
Stage1-vs-Stage4
4.091600E-02
Stage2-vs-Stage3
1.201180E-01
Stage2-vs-Stage4
7.736500E-02
Stage3-vs-Stage4
4.174200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.694400E-02
Normal-vs-AfricanAmerican
2.418400E-01
Normal-vs-Asian
7.507900E-02
Caucasian-vs-AfricanAmerican
7.772000E-01
Caucasian-vs-Asian
1.781990E-01
AfricanAmerican-vs-Asian
3.361800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.555700E-02
Normal-vs-Female
9.070200E-02
Male-vs-Female
3.404600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.301800E-01
Normal-vs-Age(41-60Yrs)
1.457150E-01
Normal-vs-Age(61-80Yrs)
5.022500E-02
Normal-vs-Age(81-100Yrs)
1.328990E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.971600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.134200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.407800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.916700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.356400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.460800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.412300E-02
Normal-vs-Daily Drinker
1.185840E-01
Normal-vs-Weekly Drinker
7.481800E-02
Normal-vs-Occasional Drinker
8.955800E-02
Normal-vs-Social Drinker
2.419000E-01
Non Drinker-vs-Daily Drinker
9.866000E-01
Non Drinker-vs-Weekly Drinker
7.722000E-01
Non Drinker-vs-Occasional Drinker
4.551000E-01
Non Drinker-vs-Social Drinker
3.033000E-01
Daily Drinker-vs-Weekly Drinker
7.887000E-01
Daily Drinker-vs-Occasional Drinker
5.208800E-01
Daily Drinker-vs-Social Drinker
3.728800E-01
Weekly Drinker-vs-Occasional Drinker
3.393000E-01
Weekly Drinker-vs-Social Drinker
2.616200E-01
Occasional Drinker-vs-Social Drinker
6.933800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.599600E-01
Normal-vs-Grade 2
5.559400E-01
Normal-vs-Grade 3
5.090800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.348300E-02
Grade 1-vs-Grade 3
3.577400E-03
Grade 1-vs-Grade 4
3.599600E-01
Grade 2-vs-Grade 3
1.720960E-01
Grade 2-vs-Grade 4
5.559400E-01
Grade 3-vs-Grade 4
5.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.808000E-02
Normal-vs-NonDiabetic
4.943600E-02
Diabetic-vs-NonDiabetic
8.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.132240E-01
Normal-vs-NoPancreatitis
5.787600E-02
Pancreatitis-vs-NoPancreatitis
5.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.733900E-02
Normal-vs-N1
8.510200E-02
N0-vs-N1
4.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.241400E-01
Normal-vs-TP53-NonMutant
1.290020E-01
TP53-Mutant-vs-TP53-NonMutant
8.174400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
